Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.
about
Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.
P2860
Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optimizing adalimumab treatmen ...... d randomized controlled trial.
@en
Optimizing adalimumab treatmen ...... d randomized controlled trial.
@nl
type
label
Optimizing adalimumab treatmen ...... d randomized controlled trial.
@en
Optimizing adalimumab treatmen ...... d randomized controlled trial.
@nl
prefLabel
Optimizing adalimumab treatmen ...... d randomized controlled trial.
@en
Optimizing adalimumab treatmen ...... d randomized controlled trial.
@nl
P2093
P2860
P1433
P1476
Optimizing adalimumab treatmen ...... d randomized controlled trial.
@en
P2093
B A Hutten
C I Busard
E M de Jong
J M van den Reek
J S van Bezooijen
M B van Doorn
S P Menting
P2860
P2888
P356
10.1186/S13063-017-1777-Y
P577
2017-02-02T00:00:00Z
P6179
1083403207